Welcome to LookChem.com Sign In|Join Free
  • or
1,2-Bis(N-cytisinyl)ethane, also known as 1,2-bis(3,4-dihydroxyphenyl)ethane, is a synthetic organic compound derived from the natural compound cytisin, which is found in the seeds of the laburnum tree. This chemical is characterized by its two cytisinyl groups attached to an ethane backbone, forming a symmetrical structure. It is known for its potential use in pharmaceutical applications, particularly as a precursor in the synthesis of various drugs and compounds. The compound's chemical formula is C16H16O4, and it exhibits a molecular weight of 272.30 g/mol. Due to its complex structure and potential applications, 1,2-Bis(N-cytisinyl)ethane is of interest in the field of organic chemistry and drug development.

492-02-4

Post Buying Request

492-02-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

492-02-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 492-02-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,9 and 2 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 492-02:
(5*4)+(4*9)+(3*2)+(2*0)+(1*2)=64
64 % 10 = 4
So 492-02-4 is a valid CAS Registry Number.

492-02-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (SML0852)  CC4  ≥98% (HPLC)

  • 492-02-4

  • SML0852-5MG

  • 1,122.03CNY

  • Detail
  • Sigma

  • (SML0852)  CC4  ≥98% (HPLC)

  • 492-02-4

  • SML0852-25MG

  • 4,518.54CNY

  • Detail

492-02-4Downstream Products

492-02-4Relevant academic research and scientific papers

Synthesis and preliminary pharmacological evaluation of some cytisine derivatives

Canu Boido, Caterina,Sparatore, Fabio

, p. 438 - 451 (2007/10/03)

Thirty-one N-derivatives of cytisine were prepared in order to modify its pharmacological profile and to obtain compounds of potential therapeutic interest either at a peripheral or central level, particularly as nicotinic ligands with improved ability to cross the blood-brain barrier. Actually, with the introduction of different kinds of substituent on the basic nitrogen of cytisine a variety of activities were observed, both in vivo (analgesic, dopamine antagonism, antihypertensive, inhibition of stress-induced ulcers, antiinflammatory, protection from PAF-induced mortality, hypoglycemic) and in vitro (positive cardio-inotropic, β-adrenergic antagonism, α1- and α2-antagonism, inhibition of PAF-induced platelet aggregation). Six randomly selected compounds were tested for the ability to recognize a central nicotinic receptor and four of them exhibited K(i) values in the range 30-163 nM.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 492-02-4